| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
American Journal of Clinical Nutrition, Vol 44, 89-98, Copyright © 1986 by The American Society for Clinical Nutrition, Inc
ORIGINAL RESEARCH COMMUNICATIONS |
M Shike, ME Shils, A Heller, N Alcock, V Vigorita, R Brockman, MF Holick, J Lane and C Flombaum
A metabolic bone disease characterized by a mineralization defect, low plasma 1,25(OH)2D, and hypercalciuria has been described in patients receiving prolonged total parenteral nutrition (TPN). Because the practice of TPN differs from center to center, we investigated 13 home TPN patients to determine whether they had similar or different bone abnormalities. They had received TPN for a mean period of 51 +/- 38 mo. Bone pain occurred in six patients and two had multiple vertebral and rib fractures (with trauma in one patient). Bone pain was mild to moderate and not incapacitating. Bone histomorphometry showed reduced bone volume, reduced osteoid with normal resorption and calcification rates. These abnormalities were associated with hypercalciuria, but the plasma levels of 1,25(OH)2D were normal. Abnormalities in bone metabolism in this group of patients suggest a fundamental decrease in bone matrix-formation rather than a mineralization defect as the underlying mechanism.
This article has been cited by other articles:
|
|
 |
|
  M. Ferrone and M. Geraci A Review of the Relationship Between Parenteral Nutrition and Metabolic Bone Disease Nutr Clin Pract, June 1, 2007; 22(3): 329 - 339. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Pazianas, C. Compher, P. Schiavone-Gatto, and B. P. Kinosian Intestinal Failure-Associated Metabolic Bone Diseases and Response to Teriparatide Nutr Clin Pract, December 1, 2006; 21(6): 605 - 609. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. L. Seidner Parenteral Nutrition-Associated Metabolic Bone Diseas JPEN J Parenter Enteral Nutr, September 1, 2002; 26(5_suppl): S37 - S42. [Abstract] [PDF]
|
|
|
|
 |
|
 K. V Haderslev, L. Tjellesen, H. A Sorensen, and M. Staun Effect of cyclical intravenous clodronate therapy on bone mineral density and markers of bone turnover in patients receiving home parenteral nutrition Am. J. Clinical Nutrition, August 1, 2002; 76(2): 482 - 488. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
American Society for Parenteral and Enteral Nutrit Guidelines for the Use of Parenteral and Enteral Nutrition in Adult and Pediatric Patients JPEN J Parenter Enteral Nutr, January 1, 2002; 26(1_suppl): 1SA - 138SA. [PDF]
|
|
|
|
|
|
D. L. Seidner and A. Licata Parenteral Nutrition-Associated Metabolic Bone Disease: Pathophysiology, Evaluation, and Treatment Nutr Clin Pract, August 1, 2000; 15(4): 163 - 170. [Abstract] [PDF]
|
|
|
|
|
|
M. Boncompain-Gerard, D. Robert, D. Fouque, and A. Hadj-Aissa Renal Function and Urinary Excretion of Electrolytes in Patients Receiving Cyclic Parenteral Nutrition JPEN J Parenter Enteral Nutr, July 1, 2000; 24(4): 234 - 239. [Abstract] [PDF]
|
|
|
|
|
|
W. G Goodman, S. Misra, J. D Veldhuis, A. A Portale, H.-J. Wang, M. E Ament, and I. B Salusky Altered diurnal regulation of blood ionized calcium and serum parathyroid hormone concentrations during parenteral nutrition1 Am. J. Clinical Nutrition, February 1, 2000; 71(2): 560 - 568. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Berkelhammer, R. J. Wood, and M. D. Sitrin Inorganic Phosphorus Reduces Hypercalciuria During Total Parenteral Nutrition By Enhancing Renal Tubular Calcium Absorption JPEN J Parenter Enteral Nutr, May 1, 1998; 22(3): 142 - 146. [Abstract] [PDF]
|
|
|
|
|
|
J. Grant Management of Nutrition Support Cases Under "Unusual Circumstances" Nutr Clin Pract, August 1, 1997; 12(4): 172 - 184. [PDF]
|
|
|
|
|
|
N. Von Wowern, B. Klausen, and E. Hylander Bone Loss and Oral State in Patients on Home Parenteral Nutrition JPEN J Parenter Enteral Nutr, March 1, 1996; 20(2): 105 - 109. [Abstract] [PDF]
|
|
|
|
|
|
J. C. Saitta, S. M. Ott, D. J. Sherrard, C. E. Walden, and E. W. Lipkin Metabolic Bone Disease in Adults Receiving Long-Term Parenteral Nutrition: Longitudinal Study With Regional Densitometry and Bone Biopsy JPEN J Parenter Enteral Nutr, May 1, 1993; 17(3): 214 - 219. [Abstract] [PDF]
|
|
|
|
|
|
W. W.K. Koo Review: Parenteral Nutrition-Related Bone Disease JPEN J Parenter Enteral Nutr, July 1, 1992; 16(4): 386 - 394. [Abstract] [PDF]
|
|
|
|
|
|
W. W.K. Koo Nutrition-Related Bone Disease JPEN J Parenter Enteral Nutr, July 1, 1992; 16(4): 400 - 400. [PDF]
|
|
|
|
|
|
ASCN/A.S.P.E.N. WORKING GROUP ON STANDARDS FOR ALU Parenteral Drug Products Containing Aluminum as an Ingredient or a Contaminant: Response to Food and Drug Administration Notice of Intent and Request for Information JPEN J Parenter Enteral Nutr, March 1, 1991; 15(2): 194 - 198. [Abstract] [PDF]
|
|
|
|
|
|
M. A. Karton, R. Rettmer, E. W. Lipkin, S. M. Ott, and A. Chait D-Lactate and Metabolic Bone Disease in Patients Receiving Long-Term Parenteral Nutrition JPEN J Parenter Enteral Nutr, March 1, 1989; 13(2): 132 - 135. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
